FONT-SIZE Plus   Neg

USPTO Affirms Gevo's Request For Reexamination Of Butamax Patent

Gevo Inc. (GEVO) announced that the U.S. Patent Office and Trademark or USPTO has denied a petition by Butamax Advanced Biofuels, LLC which would have vacated the order granting Gevo's reexamination request of Butamax's U.S. Patent No. 7,851,188. In so doing, the USPTO simultaneously affirmed its original decision that all claims challenged by Gevo in the '188 patent remain rejected as unpatentable.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT